Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

Q: What does CUSIP 05337M104 represent in this 13F holders report?

CUSIP 05337M104 is the security identifier for AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in Q2 2017?

76 institutional investors reported AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share for Q2 2017. Use the holders table for investor-level position and value details.

CUSIP: 05337M104

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Shares outstanding: 98,762,388
Total 13F shares: 27,736,858
Share change: +2,022,191
Total reported value: $305,936,220
Price per share: $11.03
Number of holders: 76
Value change: +$24,728,608
Number of buys: 40
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 05337M104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Broadfin Capital, LLC	13F	Company	4.4%	4,394,464	$42,538,000	—	31 Mar 2017	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	4.1%	4,072,809	$39,425,000	—	31 Mar 2017	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	2.2%	2,166,766	$20,973,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	1.8%	1,776,969	$17,201,000	—	31 Mar 2017	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.5%	1,524,300	$14,756,000	—	31 Mar 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.4%	1,408,240	$13,632,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	1.3%	1,292,446	$12,511,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	1.2%	1,182,210	$11,443,000	—	31 Mar 2017	13F
J. Goldman & Co LP	13F	Company	1%	997,000	$9,651,000	—	31 Mar 2017	13F
BROWN CAPITAL MANAGEMENT LLC	13F	Company	0.98%	963,981	$9,331,000	—	31 Mar 2017	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.97%	956,000	$9,254,000	—	31 Mar 2017	13F
FALCON POINT CAPITAL, LLC	13F	Company	0.89%	881,243	$8,530,000	—	31 Mar 2017	13F
Stonepine Capital Management, LLC	13F	Company	0.76%	752,410	$7,283,000	—	31 Mar 2017	13F
HEARTLAND ADVISORS INC	13F	Company	0.71%	700,000	$6,776,000	—	31 Mar 2017	13F
Tekla Capital Management LLC	13F	Company	0.63%	624,288	$6,043,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	0.55%	543,724	$5,263,000	—	31 Mar 2017	13F
JW Asset Management, LLC	13F	Company	0.45%	444,439	$4,302,000	—	31 Mar 2017	13F
Russell Investments Group, Ltd.	13F	Company	0.38%	377,440	$3,654,000	—	31 Mar 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.26%	252,073	$2,440,000	—	31 Mar 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.25%	249,863	$2,419,000	—	31 Mar 2017	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.21%	205,837	$1,993,000	—	31 Mar 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.19%	188,977	$1,830,000	—	31 Mar 2017	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.17%	170,024	$1,812,000	—	31 Mar 2017	13F
Portolan Capital Management, LLC	13F	Company	0.19%	183,866	$1,780,000	—	31 Mar 2017	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.18%	182,157	$1,763,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.15%	147,419	$1,427,000	—	31 Mar 2017	13F
BAILARD, INC.	13F	Company	0.14%	141,000	$1,365,000	—	31 Mar 2017	13F
S.c.a. Candriam	13F	Individual	0.11%	111,000	$1,075,000	—	31 Mar 2017	13F
David M. Knott	13F	Individual	0.1%	99,587	$964,000	—	31 Mar 2017	13F
Sio Capital Management, LLC	13F	Company	0.09%	91,413	$885,000	—	31 Mar 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	84,500	$818,000	—	31 Mar 2017	13F
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS	13F	Company	0.08%	77,918	$754,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	76,938	$745,000	—	31 Mar 2017	13F
STIFEL FINANCIAL CORP	13F	Company	0.06%	58,000	$561,000	—	31 Mar 2017	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.04%	43,822	$424,000	—	31 Mar 2017	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.04%	42,033	$407,000	—	31 Mar 2017	13F
EATON VANCE MANAGEMENT	13F	Company	0.04%	34,700	$336,000	—	31 Mar 2017	13F
State of New Jersey Common Pension Fund D	13F	Company	0.03%	32,915	$319,000	—	31 Mar 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	32,753	$317,000	—	31 Mar 2017	13F
SMITH ASSET MANAGEMENT GROUP LP	13F	Company	0.03%	32,590	$315,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	31,263	$302,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.03%	31,259	$302,000	—	31 Mar 2017	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.02%	23,947	$231,807	—	31 Mar 2017	13F
Trexquant Investment LP	13F	Company	0.02%	23,331	$226,000	—	31 Mar 2017	13F
ProShare Advisors LLC	13F	Company	0.02%	21,579	$209,000	—	31 Mar 2017	13F
Cutler Group LLC / CA	13F	Company	0.02%	21,065	$203,000	—	31 Mar 2017	13F
CONDOR CAPITAL MANAGEMENT	13F	Company	0.02%	16,804	$163,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.02%	16,009	$155,000	—	31 Mar 2017	13F
US BANCORP \DE\	13F	Company	0.01%	12,500	$121,000	—	31 Mar 2017	13F
CITIGROUP INC	13F	Company	0.01%	11,918	$116,000	—	31 Mar 2017	13F

Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q2 2017

As of 30 Jun 2017, Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,736,858 shares. The largest 10 holders included Broadfin Capital, LLC, DEERFIELD MANAGEMENT CO, JANUS HENDERSON GROUP PLC, ACADIAN ASSET MANAGEMENT LLC, MORGAN STANLEY, DEUTSCHE BANK AG\, PERCEPTIVE ADVISORS LLC, ARMISTICE CAPITAL, LLC, BROWN CAPITAL MANAGEMENT LLC, and FALCON POINT CAPITAL, LLC. This page lists 76 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.